1218 related articles for article (PubMed ID: 9007051)
21. Sphingosine-1-phosphate phosphohydrolase in regulation of sphingolipid metabolism and apoptosis.
Le Stunff H; Galve-Roperh I; Peterson C; Milstien S; Spiegel S
J Cell Biol; 2002 Sep; 158(6):1039-49. PubMed ID: 12235122
[TBL] [Abstract][Full Text] [Related]
22. [Sphingolipid and apoptosis].
Wang J; Hu XS; Shi JP
Sheng Li Ke Xue Jin Zhan; 2003 Jul; 34(3):217-21. PubMed ID: 14628466
[TBL] [Abstract][Full Text] [Related]
23. Measurement of ceramide and sphingolipid metabolism in tumors: potential modulation of chemotherapy.
Modrak DE
Methods Mol Med; 2005; 111():183-94. PubMed ID: 15911980
[TBL] [Abstract][Full Text] [Related]
24. Roles of sphingosine-1-phosphate in cell growth, differentiation, and death.
Spiegel S; Cuvillier O; Edsall L; Kohama T; Menzeleev R; Olivera A; Thomas D; Tu Z; Van Brocklyn J; Wang F
Biochemistry (Mosc); 1998 Jan; 63(1):69-73. PubMed ID: 9526097
[TBL] [Abstract][Full Text] [Related]
25. Sphingolipids in infectious diseases.
Hanada K
Jpn J Infect Dis; 2005 Jun; 58(3):131-48. PubMed ID: 15973004
[TBL] [Abstract][Full Text] [Related]
26. Structure-specific, quantitative methods for analysis of sphingolipids by liquid chromatography-tandem mass spectrometry: "inside-out" sphingolipidomics.
Sullards MC; Allegood JC; Kelly S; Wang E; Haynes CA; Park H; Chen Y; Merrill AH
Methods Enzymol; 2007; 432():83-115. PubMed ID: 17954214
[TBL] [Abstract][Full Text] [Related]
27. Fumonisin B1 inhibits sphingosine (sphinganine) N-acyltransferase and de novo sphingolipid biosynthesis in cultured neurons in situ.
Merrill AH; van Echten G; Wang E; Sandhoff K
J Biol Chem; 1993 Dec; 268(36):27299-306. PubMed ID: 8262970
[TBL] [Abstract][Full Text] [Related]
28. Control of metabolism and signaling of simple bioactive sphingolipids: Implications in disease.
Gangoiti P; Camacho L; Arana L; Ouro A; Granado MH; Brizuela L; Casas J; Fabriás G; Abad JL; Delgado A; Gómez-Muñoz A
Prog Lipid Res; 2010 Oct; 49(4):316-34. PubMed ID: 20193711
[TBL] [Abstract][Full Text] [Related]
29. Mycotoxin-induced elevation of free sphingoid bases in precision-cut rat liver slices: specificity of the response and structure-activity relationships.
Norred WP; Plattner RD; Dombrink-Kurtzman MA; Meredith FI; Riley RT
Toxicol Appl Pharmacol; 1997 Nov; 147(1):63-70. PubMed ID: 9356308
[TBL] [Abstract][Full Text] [Related]
30. Advances in the signal transduction of ceramide and related sphingolipids.
Liu G; Kleine L; Hébert RL
Crit Rev Clin Lab Sci; 1999 Dec; 36(6):511-73. PubMed ID: 10656539
[TBL] [Abstract][Full Text] [Related]
31. Fumonisins and other inhibitors of de novo sphingolipid biosynthesis.
Merrill AH; Wang E; Gilchrist DG; Riley RT
Adv Lipid Res; 1993; 26():215-34. PubMed ID: 8379451
[No Abstract] [Full Text] [Related]
32. Novelty of Sphingolipids in the Central Nervous System Physiology and Disease: Focusing on the Sphingolipid Hypothesis of Neuroinflammation and Neurodegeneration.
Ayub M; Jin HK; Bae JS
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298977
[TBL] [Abstract][Full Text] [Related]
33. Ceramide synthase inhibition by fumonisin B1 treatment activates sphingolipid-metabolizing systems in mouse liver.
He Q; Suzuki H; Sharma N; Sharma RP
Toxicol Sci; 2006 Dec; 94(2):388-97. PubMed ID: 16960033
[TBL] [Abstract][Full Text] [Related]
34. Ceramide: a stress signal and mediator of growth suppression and apoptosis.
Obeid LM; Hannun YA
J Cell Biochem; 1995 Jun; 58(2):191-8. PubMed ID: 7673327
[TBL] [Abstract][Full Text] [Related]
35. Importance of sphingolipids and inhibitors of sphingolipid metabolism as components of animal diets.
Merrill AH; Schmelz EM; Wang E; Dillehay DL; Rice LG; Meredith F; Riley RT
J Nutr; 1997 May; 127(5 Suppl):830S-833S. PubMed ID: 9164247
[TBL] [Abstract][Full Text] [Related]
36. Therapeutic applications of bioactive sphingolipids in hematological malignancies.
Ekiz HA; Baran Y
Int J Cancer; 2010 Oct; 127(7):1497-506. PubMed ID: 20503271
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of sphingolipid biosynthesis decreases phosphorylated ERK2 in LLC-PK1 cells.
Rentz SS; Showker JL; Meredith FI; Riley RT
Food Chem Toxicol; 2005 Jan; 43(1):123-31. PubMed ID: 15582204
[TBL] [Abstract][Full Text] [Related]
38. Role of dietary sphingolipids and inhibitors of sphingolipid metabolism in cancer and other diseases.
Merrill AH; Schmelz EM; Wang E; Schroeder JJ; Dillehay DL; Riley RT
J Nutr; 1995 Jun; 125(6 Suppl):1677S-1682S. PubMed ID: 7782925
[TBL] [Abstract][Full Text] [Related]
39. Fumonisin toxicity and sphingolipid biosynthesis.
Merrill AH; Wang E; Vales TR; Smith ER; Schroeder JJ; Menaldino DS; Alexander C; Crane HM; Xia J; Liotta DC; Meredith FI; Riley RT
Adv Exp Med Biol; 1996; 392():297-306. PubMed ID: 8850625
[TBL] [Abstract][Full Text] [Related]
40. Alteration in sphingolipid metabolism: bioassays for fumonisin- and ISP-I-like activity in tissues, cells and other matrices.
Riley RT; Norred WP; Wang E; Merrill AH
Nat Toxins; 1999; 7(6):407-14. PubMed ID: 11122537
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
